Early onset and liver failure indicating poor prognosis of infant liver failure syndrome type 1
Authors:
Open Access
- 6 June 2024
- journal article
- research article
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 19 (1) , 1-13
Abstract
Background: Infantile liver failure syndrome type 1 (ILFS1, OMIM #615,438), caused by leucyl-tRNA synthase 1 (LARS1, OMIM *151,350) deficiency, is a rare autosomal-recessive disorder. The clinical manifestations, molecular-genetic features, and prognosis of LARS1 disease remain largely elusive. Methods: Three new instances of ILFS1 with confirmed variants in LARS1, encoding LARS1, were identified. Disease characteristics were summarized together with those of 33 reported cases. Kaplan-Meier analysis was performed to assess prognostic factors in ILFS1 patients. Results: The 3 new ILFS1 patients harbored 6 novel variants in LARS1. Among the 36 known patients, 12 died or underwent liver transplantation. The main clinical features of ILFS1 were intrauterine growth restriction (31/32 patients in whom this finding was specifically described), failure to thrive (30/31), hypoalbuminemia (32/32), microcytic anemia (32/33), acute liver failure (24/34), neurodevelopmental delay (25/30), seizures (22/29), and muscular hypotonia (13/27). No significant correlations were observed between genotype and either presence of liver failure or clinical severity of disease. Kaplan-Meier analysis indicated that age of onset < 3mo (p = 0.0015, hazard ratio = 12.29, 95% confidence interval [CI] = 3.74–40.3), like liver failure (p = 0.0343, hazard ratio = 6.57, 95% CI = 1.96-22.0), conferred poor prognosis. Conclusions: Early age of presentation, like liver failure, confers poor prognosis in ILFS1. Genotype-phenotype correlations remain to be established.Keywords
Funding Information
- National Natural Science Foundation of China (82201898)
- Health industry clinical research project of Shanghai Municipal Health Commission (20224Y0281)
This publication has 13 references indexed in Scilit:
- Deep phenotyping of MARS1 (interstitial lung and liver disease) and LARS1 (infantile liver failure syndrome 1) recessive multisystemic disease using Human Phenotype Ontology annotation: Overlap and differences. Case report and review of literatureEuropean Journal of Medical Genetics, 2021
- Study of Acute Liver Failure in Children Using Next Generation Sequencing TechnologyThe Journal of Pediatrics, 2021
- Infantile Liver Failure Syndrome 1 associated with a novel variant of the LARS1 gene: Clinical, genetic, and functional characterizationClinical Genetics, 2020
- Severe course with lethal hepatocellular injury and skeletal muscular dysgenesis in a neonate with infantile liver failure syndrome type 1 caused by novel LARS1 mutationsAmerican Journal of Medical Genetics Part A, 2020
- Genotypic diversity and phenotypic spectrum of infantile liver failure syndrome type 1 due to variants in LARS1Genetics in Medicine, 2020
- Aminoacyl-tRNA synthetase deficiencies in search of common themesGenetics in Medicine, 2019
- Clinical and genetic characterisation of infantile liver failure syndrome type 1, due to recessive mutations in LARSJournal of Inherited Metabolic Disease, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Identification of a mutation in LARS as a novel cause of infantile hepatopathyMolecular Genetics and Metabolism, 2012
- Leucyl-tRNA Synthetase Is an Intracellular Leucine Sensor for the mTORC1-Signaling PathwayCell, 2012